Home R&D Page 2

R&D

Study results support Owlstone Medical’s development of breath-based diagnostic tests for liver disease
Featured

Study results support Owlstone Medical’s development of breath-based diagnostic tests for liver disease

Tess Egginton -
0
New partnership to take potential treatment for motor neurone disease into clinical trials
Featured

New partnership to take potential treatment for motor neurone disease into clinical trials

Tess Egginton -
0
Boehringer & Click to develop digital therapeutic for schizophrenia
Featured

Boehringer & Click to develop digital therapeutic for schizophrenia

Dominic Cuthbert -
0
Huadong Medicine & Exscientia to accelerate oncology drug discovery with AI
Featured

Huadong Medicine & Exscientia to accelerate oncology drug discovery with AI

Dominic Cuthbert -
0
Celltrion given the go-ahead for anti-COVID-19 antibody trial
Featured

Celltrion given the go-ahead for anti-COVID-19 antibody trial

Dominic Cuthbert -
0
Bayer and Recursion combine knowledge to advance fibrotic therapies
Featured

Bayer and Recursion combine knowledge to advance fibrotic therapies

Dominic Cuthbert -
0
Destiny Pharma and SporeGen to develop COVID-19 treatment
Featured

Destiny Pharma and SporeGen to develop COVID-19 treatment

Dominic Cuthbert -
0
AbbVie & I-Mab partner to develop anti-CD47 monoclonal antibody
Featured

AbbVie & I-Mab partner to develop anti-CD47 monoclonal antibody

Dominic Cuthbert -
0
ERS Genomics enters agreement with Applied StemCell to commercialize CRISPR gene editing services and reagents
Featured

ERS Genomics enters agreement with Applied StemCell to commercialize CRISPR gene editing services and reagents

Tess Egginton -
0
Enesi & Adelaide Uni to develop Zika vaccine
Featured

Enesi & Adelaide Uni to develop Zika vaccine

Dominic Cuthbert -
0
123...176Page 2 of 176

© 2020 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks